FDA grants Fast Track to SOT109, an ADC targeting CDH17 for advanced colorectal cancer
The U.S. Food and Drug Administration has granted Fast Track Designation to SOTIO Biotech’s investigational antibody‑drug conjugate SOT109, which targets…
The U.S. Food and Drug Administration has granted Fast Track Designation to SOTIO Biotech’s investigational antibody‑drug conjugate SOT109, which targets…